VICTORIA MUNSTERMAN: Open Payments
NPI 1992225767 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,437 in 55 payments from 14 companies in 2025. Trend: 2023 $1,656 · 2024 $1,991 · 2025 $2,437
Travel & lodging: $1,260Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 12 | $1,691 |
| Merck Sharp & Dohme LLC | 9 | $170 |
| Actelion Pharmaceuticals US, Inc. | 6 | $133 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $83 |
| Novartis Pharmaceuticals Corporation | 4 | $72 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| PFIZER INC. | 3 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Galderma Laboratories, L.P. | 1 | $23 |
Products named: VERQUVO, OPSUMIT, ELIQUIS, JARDIANCE, LEQVIO, LifeVest, FARXIGA, WINREVAIR.
Industry payments across LA — which companies pay providers there.
